Mirva Ekman Appointed Quality Director & Member of the Management Team at Bioretec
Mirva Ekman over 20 years of experience in quality and regulatory leadership.
March 7, 2025
EXECUTIVES
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Kristen Cardillo Takes Charge as Senior VP Chief Communications Officer at Zimmer Biomet
Kristen Cardillo will join the Company on March 10, 2025, to lead Zimmer Biomet’s global communications strategy, enhancing engagement with key stakeholders and amplifying the Company’s position as a leader in MedTech.
March 6, 2025
Jupiter Endovascular Appoints Fred Ong as CFO
Fred Ong brings more than 30 years of experience in building and growing venture capital-backed healthcare technology companies to his role at Jupiter Endovascular, including playing key roles in fundraising, corporate strategy, operational growth, revenue scale, and M&A exits.
February 26, 2025
Tom Arnold Appointed CEO of ViCentra
Tom Arnold brings almost 25 years of extensive leadership experience in diabetes and medical technology and has a strong track record in spearheading commercialization initiatives, business strategy, and product launches for leading medical device companies. He has held key leadership roles at Medtronic, PROCEPT BioRobotics, Boston Scientific, and Sorin Group.
February 26, 2025
Dr. Samuel A. Joseph Jr. Named Clinical Assistant Professor of Orthopaedic Surgery at HCA/USF Orthopaedic Program
Dr. Samuel A. Joseph Jr. a leader in minimally invasive and complex spine surgery, will bring his wealth of experience and innovative approach to the academic setting, enhancing the educational experience of residents and medical professionals in the field of orthopedic surgery.
February 26, 2025
Birgitte Volck Appointed Non-Executive Director at OMass Therapeutics
Dr Birgitte Volck has over 25 years of industry experience spanning R&D leadership, platform innovation, and commercialization, with a strong focus on rare diseases and precision medicine.
February 26, 2025
